Literature DB >> 27125991

Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion.

Solmaz Abdolrahimzadeh1, Pasquale Plateroti2, Fabio Scarinci3, Andrea Maria Plateroti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27125991     DOI： 10.1111/aos.13062

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  5 in total

1.  Intralenticular Ozurdex® - One Year Later.

Authors:  Kathleen A Regan; Charles R Blake; Zachary L Lukowski; Siva S R Iyer
Journal:  Case Rep Ophthalmol       Date:  2017-12-21

2.  Intracrystalline Ozurdex®: therapeutic effect maintained for 18 months.

Authors:  Rodrigo Clemente-Tomás; Delia Hernández-Pérez; Paulina Neira-Ibáñez; Francisco Farías-Rozas; Raúl Torrecillas-Picazo; Vanesa Osorio-Alayo; Antonio M Duch-Samper
Journal:  Int Ophthalmol       Date:  2017-11-30       Impact factor: 2.031

Review 3.  A review of the role of ultrasound biomicroscopy in glaucoma associated with rare diseases of the anterior segment.

Authors:  Giuseppe Mannino; Barmak Abdolrahimzadeh; Silvia Calafiore; Gianmario Anselmi; Cristina Mannino; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2016-07-29

4.  Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens.

Authors:  Partha Biswas; Krishnendu Nandi; Sneha Batra; Aniket Ginodia; Preeyam Biswas
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

5.  Misdirected ozurdex implant.

Authors:  Amber Amar Bhayana; Suneel Kumar; Shorya Vardhan Azad
Journal:  Oman J Ophthalmol       Date:  2021-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.